Request feasibility ↗Patient, procedure, embryology, andrology and cryogenic workflows designed as a controlled reproductive-medicine centre.
Request feasibility study ↗Patient, procedure, embryology, andrology and cryogenic workflows designed as a controlled reproductive-medicine centre. The investment case is tested against import dependency, procurement demand, supply resilience, attainable local content and regional export access. Portfolio definition precedes equipment selection so capital is not locked into an incompatible process.
USD 1.5–5.5M. The range covers core equipment, controlled environments, process utilities, installation, qualification, technology transfer and initial training at the stated tier. Preliminary engineering range; excludes land, finance cost, taxes and import duty. Final scope and price are confirmed at the feasibility gate.
450–1,500 m² gross; 120–400 m² high-control embryology, procedure and cryogenic areas.
Embryology requires exceptionally stable temperature, VOC, particulate and pressure control; it is commonly engineered to ISO 7/8-equivalent cleanliness without treating the clinical centre as a pharmaceutical cleanroom.
8–14 months from design basis to operational readiness, licensing dependent. Permit, authority review, civil-condition, customs and client approval delays sit outside the base programme unless expressly contracted.
Tier 1: 500–1,200 cycles/year; Tier 2: 2,000–4,000 cycles/year; clinical protocol, staffing and operating days dependent.
Capacity assumes qualified materials, stated shifts, planned maintenance and validated yield; it is not the sum of nominal machine speeds.
Highly stable HVAC, low-VOC finishes, clean gases, conditioned backup power, vibration control, cryogenic ventilation/alarm, purified water and secure data systems.
National fertility-clinic and tissue/cell handling licence, cryogenic safety and laboratory quality requirements. Typical readiness: 8–14 months.
Infinity IVD delivers the contracted facility, QMS, validation and dossier work. Certification or market authorisation is granted only by the competent independent authority.
Indicative 15–45 FTE including reproductive physicians, embryologists, nurses, andrology, quality and cryogenic support; equipment, witnessing and laboratory training over 6–12 weeks.
The feasibility equipment register identifies supplied equipment, client-supplied items, spares, initial consumables, FAT/SAT responsibility, calibration and qualification ownership.
Operating economics are issued as a sensitivity model using local labour, utilities, materials, yield, utilisation and financing assumptions; they are not a guaranteed return.
Client names and photography are disclosed only with permission; confidential programmes retain a technical envelope rather than an invented attribution.
Review programme evidence ↗The investor brief records the published assumptions, process flow, capacity tiers, regulatory route and data required for a binding feasibility package.